EGFR and neoplasm: Additionally, eBAT has been shown to exert cytotoxicity on head and neck squamous cell carcinoma and triple-negative breast cancer cells, both overexpressing EGFR and uPAR on the cell surface, and inhibit tumor growth when neck squamous cell carcinomas were implanted in nude mice [179].